» Articles » PMID: 35307409

Mechanisms Underlying Melanoma Invasion As a Consequence of MLK3 Loss

Overview
Journal Exp Cell Res
Specialty Cell Biology
Date 2022 Mar 21
PMID 35307409
Authors
Affiliations
Soon will be listed here.
Abstract

Invasive melanoma is an aggressive form of skin cancer with high incidence of mortality. The process of tumor invasion is a crucial primary step in the metastatic cascade, yet the mechanisms involved are still under investigation. Here we document a critical role for MLK3 (MAP3K11) in the regulation of melanoma cell invasion. We report the unexpected finding that cellular loss of MLK3 in melanoma cells promotes cell invasion. Cellular depletion of MLK3 expression results in the hyperactivation of ERK, which is linked to the formation of a BRAF/Hsp90/Cdc37 protein complex. ERK hyperactivation leads to enhanced phosphorylation and inactivation of GSK3β and the stabilization of c-Jun and JNK activity. Blocking of ERK and JNK signaling as well as Hsp90 activity downstream of MLK3-silencing significantly reduces melanoma invasion. Furthermore, ERK activation in the aforementioned context is coupled to MT1-MMP transcription as well as the TOM1L1-dependent localization of the membrane protease to invadopodia at the invasive front. These studies provide critical insight into the mechanisms that couple MLK3 loss with BRAF hyperactivation and its consequence on melanoma invasion.

Citing Articles

Alarmins in cutaneous malignant melanoma: An updated overview of emerging evidence on their pathogenetic, diagnostic, prognostic, and therapeutic role.

Papa V, Li Pomi F, Borgia F, Vaccaro M, Pioggia G, Gangemi S J Dermatol. 2024; 51(7):927-938.

PMID: 38775220 PMC: 11483971. DOI: 10.1111/1346-8138.17278.

References
1.
Chevalier C, Collin G, Descamps S, Touaitahuata H, Simon V, Reymond N . TOM1L1 drives membrane delivery of MT1-MMP to promote ERBB2-induced breast cancer cell invasion. Nat Commun. 2016; 7:10765. PMC: 4764922. DOI: 10.1038/ncomms10765. View

2.
Abi Saab W, Brown M, Chadee D . MLK4β functions as a negative regulator of MAPK signaling and cell invasion. Oncogenesis. 2013; 1:e6. PMC: 3412637. DOI: 10.1038/oncsis.2012.6. View

3.
Maroney A, Finn J, Connors T, Durkin J, Angeles T, Gessner G . Cep-1347 (KT7515), a semisynthetic inhibitor of the mixed lineage kinase family. J Biol Chem. 2001; 276(27):25302-8. DOI: 10.1074/jbc.M011601200. View

4.
Rattanasinchai C, Gallo K . MLK3 Signaling in Cancer Invasion. Cancers (Basel). 2016; 8(5). PMC: 4880868. DOI: 10.3390/cancers8050051. View

5.
Ueda J, Kajita M, Suenaga N, Fujii K, Seiki M . Sequence-specific silencing of MT1-MMP expression suppresses tumor cell migration and invasion: importance of MT1-MMP as a therapeutic target for invasive tumors. Oncogene. 2003; 22(54):8716-22. DOI: 10.1038/sj.onc.1206962. View